Emergency galafold pharmacy buy
Ended Awarded
- Contract number
- 36C24926F0063
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $65,674
Award facts
- Contract value 100% obligated
- $65,673.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
On December 9, 2025, the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9) awarded a delivery order to Amicus Therapeutics US, LLC for an emergency pharmaceutical buy valued at $65,673.63. This firm fixed-price delivery order, with an ultimate completion date of February 1, 2026, falls under the parent Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract (36F79724D0185), valued at $13.0 million and valid through August 31, 2029. The delivery order supports the procurement of Galafold (migalastat), a specialized enzyme replacement therapy indicated for the treatment of Fabry disease. The place of performance is Philadelphia, Pennsylvania. No set-aside designation was utilized for this award, and no subcontractor involvement was identified.
Amicus Therapeutics US, LLC, a biopharmaceutical company subsidiary registered in SAM.gov since September 2018, serves as the prime contractor and has established itself as a key supplier of Galafold to the VA across multiple VISN regions. The company's parent Federal Supply Schedule contract enables various VA Veterans Integrated Service Networks to place task orders for this specialized medication, supporting the VA's mission of providing advanced pharmaceutical treatments to veterans. The delivery order mechanism allows VISN 9 to efficiently obtain this critical medication to address emergency pharmaceutical needs for eligible veterans.
Quick answers
Who was awarded contract 36C24926F0063?
36C24926F0063 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on December 9, 2025.
How much is contract 36C24926F0063 worth?
The government has obligated $65,674 on 36C24926F0063.
Is contract 36C24926F0063 an order under another contract?
Yes. 36C24926F0063 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926F0063 competed?
The extent of competition for 36C24926F0063 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award